Literature DB >> 20584707

Giant cell arteritis in Asians: a comparative study.

Luciano S Pereira1, Michael K Yoon, Thomas N Hwang, Jenny E Hong, Kathyrn Ray, Travis Porco, Timothy J McCulley.   

Abstract

BACKGROUND: Giant cell arteritis (GCA) is a common systemic vasculitis, with a presumed Caucasian predominance. The occurrence of GCA in Asians has rarely been addressed. This study aims to assess the incidence of giant cell arteritis in Asians.
METHODS: In this retrospective review, the self-reported ethnicities of patients with biopsy-proven GCA at the University of California-San Francisco (UCSF) were recorded. Ethnic distribution of the patient population served by UCSF was estimated from an age- and sex-matched control group. The odds ratio for each ethnicity (Asian and Caucasian) was determined and compared using Fisher's exact test and logistic regression analysis.
RESULTS: The ethnic distribution of the 38 patients with positive temporal artery biopsies were as follows: Caucasian n=31 (81.6%), Asian n=1 (2.6%) and other n=6 (15.8%). The ethnic distribution of the patient population served by UCSF was as follows: Caucasian 42%, Asian 28% and other 30%. The difference in the proportion of GCA in Asians and Caucasians was statistically significant (OR 0.049 (95% CI 0.0065 to 0.374), p=0.0036).
CONCLUSIONS: In our patient population, GCA was seen 20 times less frequently in Asian than Caucasian patients. Although this difference is significantly different (p=0.036), given the small sample size and wide CI this should be viewed as a rough estimate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584707     DOI: 10.1136/bjo.2009.177220

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  18 in total

1.  Ophthalmic presentation of giant cell arteritis in African-Americans.

Authors:  S T Garrity; M Pistilli; M S Vaphiades; N Q Richards; P S Subramanian; P R Rosa; B L Lam; B J Osborne; G T Liu; K E Duncan; R K Shin; N J Volpe; K S Shindler; M S Lee; M L Moster; E H Tracey; S E Cuprill-Nilson; M A Tamhankar
Journal:  Eye (Lond)       Date:  2016-09-16       Impact factor: 3.775

2.  Giant cell arteritis in patients of Indian Subcontinental descent in the UK.

Authors:  N Tan; J Acheson; N Ali
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

Review 3.  Clinical features of polymyalgia rheumatica and giant cell arteritis.

Authors:  Carlo Salvarani; Nicolò Pipitone; Annibale Versari; Gene G Hunder
Journal:  Nat Rev Rheumatol       Date:  2012-07-24       Impact factor: 20.543

Review 4.  The immunopathology of giant cell arteritis: diagnostic and therapeutic implications.

Authors:  Cornelia M Weyand; Y Joyce Liao; Jörg J Goronzy
Journal:  J Neuroophthalmol       Date:  2012-09       Impact factor: 3.042

5.  Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study.

Authors:  Gelareh Homayounfar; Natalie Nardone; Durga S Borkar; Vivien M Tham; Travis C Porco; Wayne T A Enanoria; John V Parker; Aleli C Vinoya; Aileen Uchida; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2013-07-24       Impact factor: 5.258

6.  Silent giant cell arteritis in an elderly Korean woman.

Authors:  Dong Min Cha; Taeseung Lee; Gheeyoung Choe; Hee Kyung Yang; Jeong-Min Hwang
Journal:  Korean J Ophthalmol       Date:  2013-04-25

7.  A review of specialties performing temporal artery biopsies in Ontario: a retrospective cohort study.

Authors:  Jonathan A Micieli; Robert Micieli; Edward A Margolin
Journal:  CMAJ Open       Date:  2015-07-17

8.  Ischemic optic neuropathy and cataract extraction: What do I need to know?

Authors:  Timothy J McCulley
Journal:  Oman J Ophthalmol       Date:  2012-09

9.  Epidemiology of Vasculitides in Khorasan Province, Iran.

Authors:  Mohammadhassan Jokar; Zahra Mirfeizi
Journal:  Iran J Med Sci       Date:  2015-07

10.  Giant cell arteritis presenting as choroidal infarction.

Authors:  Nikolaos Kopsachilis; Maria Pefkianaki; Anca Marinescu; Sobha Sivaprasad
Journal:  Case Rep Ophthalmol Med       Date:  2013-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.